Dietary antioxidants and cardiovascular disease

Current Opinion in Lipidology

Volumn 16, Issue 1, 2005, Pages 47-54

  Blomhoff, Rune ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Antioxidant network; Redox active compounds; Reduction potential

Indexed keywords

ALPHA TOCOPHEROL; ANTHOCYANIN; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BODY WISE RIGHT CHOICE AM; CENTRUM SILVER; CHONDROITIN SULFATE; ENZYME; GINKGO BILOBA EXTRACT; GNC ULTRA MEGA GOLD; HYPERICUM PERFORATUM EXTRACT; ISPAGULA; MEDOX; METAMUCIL ORANGE; MULTIVITAMIN; OCUVITE EKSTRA; THERAGRAN; WOMEN'S ULTRA MEGA;

BERRY; BEVERAGE; BROCCOLI; BRUSSELS SPROUT; CABBAGE; CARDIOVASCULAR DISEASE; CARROT; CAULIFLOWER; CLINICAL TRIAL; DIET; DIET SUPPLEMENTATION; ENZYME MECHANISM; FRUIT; GARLIC; HUMAN; KALE; META ANALYSIS; NONHUMAN; NUT; ONION; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PLANT SEED; PRIORITY JOURNAL; REVIEW; SPICE; SPINACH; SYSTEMATIC REVIEW; TOMATO; VEGETABLE;

ALLIUM SATIVUM; ANIMALIA; BRASSICA OLERACEA VAR. ACEPHALA; BRASSICA OLERACEA VAR. BOTRYTIS; BRASSICA OLERACEA VAR. CAPITATA; BRASSICA OLERACEA VAR. GEMMIFERA; DAUCUS CAROTA; LYCOPERSICON ESCULENTUM; SPINACIA OLERACEA;

EID: 14744283955     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200502000-00009     Document Type: Review

References (57)

1. Demmig-Adams B, Adams WW III. Antioxidants in photosynthesis and human nutrition. Science 2002; 298:2149-2153.
2. Benzie IF. Evolution of dietary antioxidants. Comp Biochem Physiol 2003; 136:113-126. In this paper, different strategies of antioxidant defence are outlined, as well as evolution of dietary antioxidants from the perspectives of plant need and our current dietary requirements.
3. Bandyopadhyay D, Chattopadhyay A, Ghosh G, Datta AG. Oxidative stress-induced ischemic heart disease: protection by antioxidants. Curr Med Chem 2004; 11:369-387. This review discusses the oxygen free radical involvement in the genesis of ischemic heart disease, the mechanism(s) of oxidative myocardial damage and the endogenous as well as exogenous antioxidant defence systems.
4. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury. Part II: Animal and human studies. Circulation 2003; 108:2034-2040. These authors discuss evidence consistent with a role for ROS in models of human disease and they comment on the outcomes of clinical antioxidants trials. They state that it is premature to conclude that the oxidation hypothesis of disease causality has been adequately tested.
5. Sanchez-Quesada JL, Benitez S, Ordonez-Llanos J. Electronegative low-density lipoprotein. Curr Opin Lipidol 2004; 15:329-335. Recent reports have provided new evidence on a putative atherogenic role of electronegative LDL This review focuses on and discusses these new findings.
6. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 1997.
7. Report of the joint WHO/FAO expert consultation. Diet, nutrition and the prevention of chronic diseases. WHO Technical Report Series, No. 916 (TRS 916); 2003.
8. Abudu N, Miller JJ, Attaelmannan M, Levinson SS. Vitamins in human arteriosclerosis with emphasis on vitamin C and vitamin E. Clin Chim Acta 2004; 339:11-25.
9. Brigelius-Flohe R, Kelly FJ, Salonen JT, et al. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 2002; 76:703-716.
10. Cooper DA. Carotenoids in health and disease: recent scientific evaluations, research recommendations and the consumer. J Nutr 2004; 134:221S-224S.
11. Stanner SA, Hughes J, Kelly CN, Buttriss J. A review of the epidemiological evidence for the 'antioxidant hypothesis'. Public Health Nutr 2004; 7:407-422. The British Nutrition Foundation was recently commissioned by the Food Standards Agency to conduct a review of the government's research programme on Antioxidants in Food. Part of this work is presented in this paper. The authors conclude that the suggestion that antioxidant supplements can prevent chronic diseases has not been proved by the findings of published intervention trials. Further evidence regarding the efficacy, safety and appropriate dosage of antioxidants is needed.
12. Hasnain BI, Mooradian AD. Recent trials of antioxidant therapy: what should we be telling our patients? Cleve Clin J Med 2004; 71:327-334. This paper reviews important studies on the effects of antioxidant supplements and examines whether the current evidence supports, confirms or rejects the presumed protective role. It is concluded that the current evidence does not support the indiscriminate use of supplements to prevent or reduce cardiovascular disease.
13. Eidelman RS, Hollar D, Hebert PR, et al. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med 2004; 164:1552-1556. A metaanalysis of seven large-scale randomized trials of the effectiveness of vitamin E in the treatment and prevention of cardiovascular disease.
14. Shekelle PG, Morton SC, Jungvig LK, et al. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med 2004; 19:380-389. A metaanalysis of placebo-controlled randomized trials. Eighty-four eligible trials were identified. For the outcomes of all-cause mortality, cardiovascular mortality, fatal or nonfatal myocardial infarction, and blood lipids, neither supplements of vitamin E alone nor vitamin E given with other agents yielded a statistically significant beneficial or adverse pooled relative risk.
15. Vivekananthan DP, Penn MS, Sapp SK, et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003; 361:201 7-2023. This paper reports a metaanalysis of seven randomized trials of vitamin E treatment and, separately, eight of β-carotene treatment; all trials included 1000 or more patients. The dose range for vitamin E was 50-800 IU, and for β-carotene it was 15-50 mg. Follow-up period ranged from 1.4 to 12.0 years.
16. McCord JM. The evolution of free radicals and oxidative stress. Am J Med 2000; 108:652-659.
17. Chemical kinetics I and II. In: Laidler KJ, Meiser JH, Sanctuary BC, editors. Physical chemistry. 4th ed. Boston, MA: Houghton Mifflin; 2003. pp. 361-493.
18. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys 1993; 300:535-543.
19. Chemical reactions and oxidation and reduction. In: Hill JW, Feigl DM, Baum SJ, editors. Chemistry of life: an introduction to general, organic and biological chemistry. 4th ed. New York Macmillan; 1993. pp. 107-155.
20. Lindsay DG, Astley SB. European research on the functional effects of dietary antioxidants: EUROFEDA. Mol Aspects Med 2002; 23:1-38.
21. Upston JM, Terentis AC, Stocker R. Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J 1999; 13:977-994.
22. Thomas SR, Stocker R. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis. Free Radic Biol Med 2000; 28:1795-1805.
23. Packer L, Weber SU, Rimbach G. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J Nutr 2001; 131:369S-373S.
24. Miller NJ, Rice-Evans CA. Spectrophotometric determination of antioxidant activity. Redox Rep 1996; 2:161-168.
25. DeLange RJ, Glazer AN. Phycoerythrin fluorescence-based assay for peroxyl radicals: a screen for biologically relevant protective agents. Anal Biochem 1989; 177:300-306.
26. Cao G, Alessio HM, Cutler RG. Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 1993; 14:303-311.
27. Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': the FRAP assay. Anal Biochem 1996; 239:70-76.
28. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001; 30:1191-1212.
29. Halvorsen BL, Holte K, Myhrstad MC, et al. A systematic screening of total antioxidants in dietary plants. J Nutr 2002; 132:461-471.
30. Dragland S, Senoo H, Wake K, et al. Several culinary and medicinal herbs are important sources of dietary antioxidants. J Nutr 2003; 133:1286-1290. This paper assessed the contribution of culinary and medicinal herbs to the total intake of dietary antioxidants. The results demonstrate that there is more than a 1000-fold difference among antioxidant concentrations of various herbs. It was concluded that, in a normal diet, intake of herbs may contribute significantly to the total intake of plant antioxidants, and be an even better source of dietary antioxidants than many other food groups such as fruits, berries, cereals and vegetables.
31. Cao G, Sofic E, Prior RL. Antioxidant capacity of tea and common vegetables. J Agric Food Chem 1996; 4:3426-3431.
32. Wang H, Cao G, Prior RL. Total antioxidant capacity of fruits. J Agric Food Chem 1996; 44:701-705.
33. Miller HE, Rigelhof F, Marquart L, et al. Antioxidant content of whole grain breakfast cereals, fruits and vegetables. J Am Coll Nutr 2000; 19:312S-319S.
34. Wu X, Beecher GR, Holden JM, et al. Lipophilic and hydrophilic antioxidant capacities of common foods in the United States. J Agric Food Chem 2004; 52:4026-4037. Both lipophilic and hydrophilic antioxidant capacities were determined using the ORAC assay on over 100 different kinds of foods, including fruits, vegetables, nuts, dried fruits, spices, cereals, infant, and other foods. The data demonstrated that processing can have significant effects on ORAC.
35. Sun J, Chu YF, Wu X, Liu RH. Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem 2002; 50:7449-7454.
36. Proteggente AR, Pannala AS, Paganga G, et al. The antioxidant activity of regularly consumed fruit and vegetables reflects their phenolic and vitamin C composition. Free Radic Res 2002; 36:217-233.
37. Aviram M, Dornfeld L, Rosenblat M, et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 2000; 71:1062-1076.
38. Kaplan M, Hayek T, Raz A, et al. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr 2001; 131:2082-2089.
39. Aviram M, Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 2001; 158:195-198.
40. Aviram M, Rosenblat M, Gaitini D, et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 2004; 23:423-433. This paper investigated the effects of pomegranate juice consumption on the progression of carotid lesions and changes in oxidative stress and blood pressure. in atherosclerotic patients with carotid artery stenosis. Ten patients were supplemented with juice for 1 year and five of them continued for up to 3 years. The results suggest that pomegranate juice consumption decreases carotid intima-media thickness and systolic blood pressure.
41. Feldman EB. The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease. J Nutr 2002; 132:1062S-1101S.
42. Anderson KJ, Teuber SS, Gobeille A, et al. Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J Nutr 2001; 131:2837-2842.
43. Sabate J. Nut consumption, vegetarian diets, ischemic heart disease risk and all-cause mortality: evidence from epidemiological studies. J Nutr 1999; 70:500-503.
44. Ros E, Nunez I, Perez-Heras A, et al. A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 2004; 109:1609-1614. To test the hypothesis that walnut intake will reverse endothelial dysfunction, this paper randomized in a crossover design 21 hypercholesterolemic men and women to a cholesterol-lowering diet and a similar diet rich in walnuts for 4 weeks. The authors concluded that substituting walnuts for monounsaturated fat in a Mediterranean diet improves endothelium-dependent vasodilation.
45. Qualified claims about cardiovascular disease risk. US Food and Drug Administration. Docket No. 02P-0292; March 2004. http://www.cfsan.fda.-gov/~dms/ qhcnuts3.html.
46. Moskaug JO, Carlsen H, Myhrstad M, Blomhoff R. Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech Ageing Dev 2004; 125:315-324. This review describes some of the many effects of quercetin, and how molecular imaging using transgenic reporter mice may serve as a tool to study the integrated influence of quercetin and other dietary phytochemicals on gene expression in vivo.
47. Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci U S A 1997; 94:10367-10372.
48. Talalay P. Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors 2000; 12:5-11.
49. Carlsen H, Alexander G, Austenaa LM, et al. Molecular imaging of the transcription factor NF-kappaB, a primary regulator of stress response. Mutat Res 2004; 551:199-211. A wide range of environmental stress and human disorders involves inappropriate regulation of NF-κB. The authors have developed transgenic mice that express luciferase under the control of NF-κB, enabling real-time noninvasive imaging of NF-κB activity in intact animals during disease progression and after dietary intervention.
50. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, et al. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA 2004; 101:2040-2045. Induction of a family of phase 2 genes encoding for proteins that protect against the damage of electrophiles and reactive oxygen intermediates is potentially a major strategy for reducing the risk of chronic degenerative diseases. This paper presents important aspects of the mechanism showing that such regulation takes place.
51. Zoete V, Rougee M, Dinkova-Kostova AT, et al. Redox ranking of inducers of a cancer-protective enzyme via the energy of their highest occupied molecular orbital. Free Radic Biol Med 2004; 36:1418-1423. In this study it is reported that the tendency of 30 plant phenylpropenoids and synthetic analogs to release electrons correlates linearly with their potency in inducing the activity of NAD(P)H: quinone reductase (NQO1), a prototypic phase 2 enzyme.
52. Steele VE, Boone CW, Dauzonne D, et al. Correlation between electron-donating ability of a series of 3-nitroflavones and their efficacy to inhibit the onset and progression of aberrant crypt foci in the rat colon. Cancer Res 2002; 62:6506-6509.
53. Carlsen H, Myhrstad MC, Thoresen M, et al. Berry intake increases the activity of the gamma-glutamylcysteine synthetase promoter in transgenic reporter mice. J Nutr 2003; 133:2137-2140. The development of transgenic mice that express luciferase controlled by the γ-glutamylcysteine synthetase heavy subunit promoter is described. The treatment of mice with berry juices generally increased luciferase activity in brain and skeletal muscle compared with controls fed water.
54. Carlsen H, Moskaug JO, Fromm SH, Blomhoff R. In vivo imaging of NF-kappa B activity. J Immunol 2002; 168:1441-1446.
55. Letter regarding dietary supplement health claim for antioxidant vitamins and certain cancers. US Food and Drug Administration, Center for Food Safety and Applied Nutrition; 2001.
56. Dietary Reference Intakes. Proposed definitions and plan for review of dietary antioxidants and related compounds. Institute of Medicine, Food and Nutrition Board. Washington DC: National Academy Press; 1998.
57. Tribble DL. AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E, and beta-carotene: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 99:591-595.